← Back to Search

Behavioral Intervention

Intervention Arm for Opioid Use Disorder (STAMINA Trial)

N/A
Waitlist Available
Led By James A Swartz, PhD
Research Sponsored by Chestnut Health Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month study period
Awards & highlights

STAMINA Trial Summary

This trial is testing whether telemedicine can help syringe exchange clients get access to treatment for opioid addiction, by linking them to care immediately.

Eligible Conditions
  • Opioid Use Disorder

STAMINA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month study period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month study period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Linkage to medication for opioid use disorder (MOUD)
Secondary outcome measures
Detected non-prescribed opioids
Medication for opioid use disorder (MOUD) treatment engagement
Medication for opioid use disorder (MOUD) treatment retention
+1 more

STAMINA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Participants will receive the telemedicine linkage intervention.
Group II: Control ArmActive Control1 Intervention
Participants will receive a standard referral to an in-person MOUD treatment appointment, which typically occurs within 24-72 hours. They also receive a bus pass to cover transportation (both directions), as well as an appointment reminder card.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telemedicine Linkage Intervention
2020
N/A
~280

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoOTHER
611 Previous Clinical Trials
1,560,226 Total Patients Enrolled
Chestnut Health SystemsLead Sponsor
21 Previous Clinical Trials
23,090 Total Patients Enrolled
James A Swartz, PhDPrincipal InvestigatorUniversity of Illinois at Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Illinois
How old are they?
18 - 65
65+
What site did they apply to?
University of Illinois at Chicago Community Outreach Intervention Projects (COIP) Field Site
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
formation/NLM/NIH, NCBI. “Gprobe”. 2017. Web. <https://github.com/ncbi/gprobe>..Journal
Gprobe
Information/NLM/NIH, NCBI. 2017. “Gprobe”. GitHub repository. https://github.com/ncbi/gprobe.
clinicaltrials.govStudy
Project STAMINA (Syringe Service Treatment Access for Medication-assisted Intervention Through NAvigation)
2020. "Project STAMINA (Syringe Service Treatment Access for Medication-assisted Intervention Through NAvigation)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04575324.
~59 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top